We want to connect, learn from and work with you

Multi-stakeholder community to promote patient access to novel cellular therapies


GoCART is a multi-stakeholder coalition of patient representatives, health care professionals, pharmaceutical companies, regulators, Health Technology Assessment (HTA) bodies and reimbursement agencies, and medical organisations, collaborating to maximise the potential of cellular therapies manufactured from cells and tissues of hematopoietic origin.

News & Updates

GoCART clinical case discussion series on CART

After the first three successful GoCART Clinical Case Discussions on CAR T-cells it is our great pleasure to invite you to the next meeting that will take place on 18th January from 4-5 pm CET. The meeting will be hosted by Dr. Osman Ahmed and Drs. Locatelli, Ghorashian and Bader as our panel experts!

Read More »

What We Do


— Data Harmonisation

Create a central EU data registry for the harmonised collection of clinical data on patients treated with cellular and gene therapies from cells and tissues of hematopoietic origin to support collaborative studies and regulatory decision making.


— Standards of Care

Develop harmonised guidelines on patient and product management for health care professionals. Reduce inspection burden and redundancies by developing and implementing consensus-driven requirements and qualification standards for clinical teams delivering cellular and gene therapies from cells and tissues of hematopoietic origin.



Leverage the central Registry for gene and cellular therapy as a suitable data source for HTA.


— Education

Develop a central portal for both patients and caregivers as well as health care professionals to access training and educational materials on cellular therapies and to streamline the training supply to minimise duplication of efforts. Develop a consensus-based curriculum that meets the needs of multiple stakeholders.


— Policy and Advocacy

Represent and promote the interests of the GoCART coalition and its stakeholders in EU policy making by engaging with EU institutions and other relevant stakeholders.


— Scientific Excellence

Stimulate scientific discussion across stakeholders, facilitate the set-up of joint research projects and avoid duplication of scientific efforts.


Our founders